COMT and Parkinson disease: These data can contribute to our knowledge about the mechanisms implicated in the cardiovascular dysfunction observed in PD and suggest that COMT inhibitors, with preferential affinity for MB-COMT over S-COMT, could improve the response of cardiac noradrenergic pathway in PD.